Works matching IS 13406868 AND DT 2018 AND VI 25 AND IP 4
Results: 15
The long and winding road for overcoming resistance to hormone therapy in breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 377, doi. 10.1007/s12282-018-0876-2
- By:
- Publication type:
- Article
Do you know how to get the J-START quality assurance guideline?
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 375, doi. 10.1007/s12282-018-0867-3
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 479, doi. 10.1007/s12282-018-0848-6
- By:
- Publication type:
- Article
Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 470, doi. 10.1007/s12282-018-0847-7
- By:
- Publication type:
- Article
Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 464, doi. 10.1007/s12282-018-0846-8
- By:
- Publication type:
- Article
Preoperative breast MRI: reproducibility and significance of findings relevant to nipple-areolar complex involvement.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 456, doi. 10.1007/s12282-018-0845-9
- By:
- Publication type:
- Article
OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 447, doi. 10.1007/s12282-018-0844-x
- By:
- Publication type:
- Article
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 438, doi. 10.1007/s12282-018-0843-y
- By:
- Publication type:
- Article
Effect of the normal mammary differentiation regulator ELF5 upon clinical outcomes of triple negative breast cancers patients.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 489, doi. 10.1007/s12282-018-0842-z
- By:
- Publication type:
- Article
Correlation of FANCM expression with clinical factors in luminal B breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 431, doi. 10.1007/s12282-018-0841-0
- By:
- Publication type:
- Article
Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 416, doi. 10.1007/s12282-018-0840-1
- By:
- Publication type:
- Article
Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 407, doi. 10.1007/s12282-018-0839-7
- By:
- Publication type:
- Article
Clinical development of CDK4/6 inhibitor for breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 402, doi. 10.1007/s12282-017-0827-3
- By:
- Publication type:
- Article
Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 392, doi. 10.1007/s12282-017-0812-x
- By:
- Publication type:
- Article
Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 4, p. 379, doi. 10.1007/s12282-017-0772-1
- By:
- Publication type:
- Article